News Release

Berlin will host Targeting Mitochondria 2022 with challenging visions

Meeting Announcement

Mitochondria-Microbiota Task Force

World Mitochondria Society Congress

image: 13th World Congress on Targeting Mitochondria view more 

Credit: Credits to the World Mitochondria Society

The 13th World Congress on Targeting Mitochondria will take place this year at the Steigenberger Hotel Am Kanzleramt, Berlin, Germany & Online from October 26th to 28th.

Targeting Mitochondria 2022 will come with many hot topics related to mitochondria function and dysfunction in health & disease. All topics will be presented by selected speakers.

Please find here some speakers' topics related to Targeting Mitochondria 2022: Mitochondrial SignalingMitochondrial DiseasesCancerCardiovascular Diseases (Stroke), SepsisFatty Liver DiseaseRespiratory DiseasesSchizophreniaBrain Injury and Neurological DiseasesAgeing, Gene/metabolic Disorders, Extracellular Vesicles and Mitochondrial DysfunctionsExtracellular Vesicles TherapyMitochondrial MedicineMitochondrial TransplantationMitochondrial TransferMitochondrial Genome EngineeringTranslational TherapyPhoto-medicineInfrared LightMitochondria and Vision

 

More about the speakers & their talks.

You can have an idea about the attendees

Among Targeting Mitochondria 2022 Supporters: Mint therapeutics, Khondrion B.V. and CureMito Foundation.

 

Abstract Submission

  • Short Oral Presentation submission deadline: October 7
  • Poster Presentation submission deadline: October 14

More details on abstract submission

 

Best Mitochondria Image Contest

The Best Mitochondria Image 2022 will be chosen during the conference and the winner will get a free registration for Targeting Mitochondria 2023.

Image submission guidelines.

 

Registration

Registration for both in-person or online participation is possible. Registration details.

Early bird registration deadline: August 31.

 

Targeting Mitochondria 2022 Speakers:

Douglas C. Wallace, Children's Hospital of Philadelphia, USAKeynote Speech - Mitochondrial Medicine: Present and Future

James McCully, Boston Children’s Hospital, USA Recent Advances in Mitochondrial Transplantation Therapy

Jan Smeitink, Khondrion B.V., the Netherlands The Randomized Controlled Phase 2b KHENERGYZE Trial of Sonlicromanol in Primary Mitochondrial Disease MELAS Spectrum Disorders: Topline Results

Lori Buhlman, Midwestern University Glendale, USA Folic Acid Supplementation Improves Drosophila Parkin Loss-of-Function Phenotype and Decreases Mitochondrial Hydrogen Peroxide Levels in Vulnerable Dopaminergic Neurons

Michael Weber, President of European Laser Academy, GermanyMitochondrial and Photo-Medicine - Recent Clinical Applications

Marc Germain, Université du Québec à Trois-Rivières, Canada The Role of Extracellular Vesicles in Mitochondrial Quality Control Mechanisms

Ines Khadimallah, Lausanne University Hospital, SwitzerlandMitochondrial, Exosomal miR137-COX6A2 in Schizophrenia

Cora Weigert, University Hospital Tuebingen, GermanyExercise, Mitochondrial Adaptations, and Fatty Liver

Pedro Silva-Pinheiro, University of Cambridge, United Kingdom The Potential of Mitochondrial Genome Engineering 

Maria Fazzari, University of Milano, ItalyGM1 oligosaccharide as mitochondrial modulator: implications in neurological diseases 

Lefkothea C. Papadopoulou, Aristotle University of Thessaloniki, GreeceA Novel PTD-mediated IVT-mRNA delivery platform developed for Protein Replacement Therapy for genetic/metabolic disorders

Devika S Manickam, Duquesne University, USAEV-Mitochondria as a Promising Therapeutic for Mitochondrial Dysfunction

Jessica Spinelli, Whitehead Institute for Biomedical Research, USAUnlocking the potential of the mammalian electron transport chain

Marc G. Jeschke, University of Toronto, CanadaMitochondrial responses to a massive trauma-determinant of survival

Ian J. Holt, Biodonostia Health Research Institute, Spain2-Deoxy-D-glucose couples mitochondrial DNA replication with mitochondrial fitness

Michael Teitell, University of California, USAMitochondrial Transfer via MitoPunch

Raghavan Pillai Raju, Medical College of Georgia, USAMitochondrial targeting in aging and injury

Camilla Bean, University of Padova, Italy – The Multiple Facets of the Mitochondria Shaping Protein Opa1 in Adipocytes: From Epigenetic to Tissue Plasticity

Qun Sophia Zang, Loyola University Chicago Health Science Campus, USA Regulation of Mitochondrial Signaling in Cardiomyopathy During Sepsis

Julia A. Vorholt, ETH Zurich, Switzerland Mitochondria Transplantation Between Living Cells

Paige Arnold, Memorial Sloan Kettering Cancer Center, USA – A Non-canonical Tricarboxylic Acid Cycle Underlies Cellular Identity

Maik Hüttemann, Wayne State University, USANoninvasive treatment of brain ischemia-reperfusion injury with near infrared light: working toward clinical implementation

Melanie Walker, University of Washington Medical School, USAAutologous Mitochondrial Transplant for Cerebral Ischemia

Anna Krasnodembskaya, Queen's University Belfast, United Kingdom The Impact of Mesenchymal Stromal Cell Extracellular Vesicles on Mitochondrial Dysfunction in Acute Respiratory Distress Syndrome

Nicole Noren Hooten, NIH, USAMitochondria in Extracellular Vesicles and Aging

Dhyan Chandra, Roswell Park Comprehensive Cancer Center, USA – Targeting the Mitochondrial Unfolded Protein Response in Prostate Cancer

John Ball, from the National Institute of Health, USAMitochondria in Retinal Photoreceptors: More than Meets the Eye

More about the speakers & their talks.

 

About the World Mitochondria Society:

The World Mitochondria Society emerged seamlessly out of a series of yearly conferences organized since 2010 by the International Society of Antioxidants in Nutrition and Health. The current president of the WMS is Volkmar Weissig, Midwestern University, College of Pharmacy Glendale, USA.

For more information visit the WMS website: www.wms-site.com.


Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.